ArticleFrontiers in veterinary science2026
Analysis of antibiotic resistance phenotypes and molecular variants in antibiotic resistance genes among
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Antibiotic treatment represents one of the available control strategies for managing clinical outbreaks in flocks infected with Methods: In present study, the minimum inhibitory concentrations (MICs) of 12 commonly used antimicrobial agents were evaluated for 35 MS isolates collected between 2018 and 2025 using the broth microdilution method. In addition, the molecular variation characteristics of the quinolone resistance-determining region (QRDR) and macrolide resistance-associated genes were analyzed in the same 35 MS strains. Results: All MS isolates exhibited low minimum inhibitory MIC values for tylvalosin (MIC₉₀ = 0.25 μg/mL) and valnemulin (MIC₉₀ = 0.0078 μg/mL), indicating high Conclusion: The results of this study would deepen veterinarians' understanding of resistance mechanisms and provide scientifically validated data to guide the rational use of existing antimicrobials, as well as to support the development of novel therapeutics against MS infection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.